Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Definitive Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

NCT02508636 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02508636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02508636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Definitive Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
December 22, 2015
Completion date
August 31, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic nodal, prostatic neoplasms